Oppenheimer analyst Silvan Tuerkcan downgraded Exelixis (NASDAQ: EXEL) from Outperform to Perform with a price target of $33.00 (from $41.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE